IP Library Granted Patent US 9,012,212
Granted Patent B2
US 9,012,212 · App. 12/596,390 · Granted Apr 21, 2015

Method and device for continuous membrane adsorption

Inventors: Marc Antonius Theodorus Bisschops (Breda, NL); Jozef Anton Mari Pennings (Den Haag, NL); Jacob Arthur Tijsterman (Haarlem, NL)
Assignee: Xendo Holding B.V.
C07K1/18B01D15/1807B01D15/1821B01D15/1864C07K1/22C07K1/36G01N30/468G01N2030/527
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,012,212
App. No.
12/596,390
Granted
Apr 21, 2015
Kind
B2
Abstract

A method and system is provided for yielding biopharmaceutical products involving a chromatographic separation process. The method comprises: providing a plurality of membrane adsorber cartridges; providing a plurality of valves, communicatively coupled to said plurality of membrane adsorber cartridges; and switching the valves, so as to interconnect said membrane adsorber cartridges to operate in a countercurrent flow mode. The system comprises multiple membrane adsorber cartridges that are interconnected and configured to operate in a countercurrent flow mode. Furthermore, the configuration comprises a valve assembly that allows the cartridges to be subjected to different steps in the process by automatic switching of the valves. In this way, cartridges are recycled many times during the purification of a batch.

Claims (31)

1. A method for providing a biopharmaceutical product involving a chromatographic separation process, the method comprising:

providing a plurality of membrane adsorber cartridges;

providing a plurality of valves, communicatively coupled to said plurality of membrane adsorber cartridges, at least some of the cartridges being connected in series; and

switching the valves, so as to subsequently subject said membrane adsorber cartridges to a number of process steps of a process cycle; to thereby operate in a countercurrent flow mode;

performing a binding action including providing a process fluid in at least one of said plurality of membrane adsorber cartridges for binding a component of interest to a membrane adsorber provided in said at least one membrane adsorber cartridge; and

performing an eluting action including providing an elution fluid flow in said at least one adsorber cartridge to elute a product of interest from the at least one membrane adsorber; and

providing the product of interest as the biopharmaceutical product; wherein

a first switching action including switching at least one first valve of the valve assembly initiates the elution action; and wherein

a second switching action including switching at least one second valve of the valve assembly initiates said binding action; and wherein

the first valve and the second valve are switched asynchronously, thereby controlling the residence time of the membrane adsorber cartridge in each zone individually, and

wherein said eluting action further includes:

a washing action including providing a buffer in said membrane adsorber cartridge to displace said process fluid from a dead volume in said at least one membrane adsorber cartridge by said buffer; followed by

a fourth switching action including switching at least one valve of the valve assembly to initiate providing said elution fluid flow to elute the product of interest.

2. A method according to claim 1 , wherein said binding action further includes;

a regenerating action including providing at least one regenerating fluid in said at least one adsorber cartridge to the membrane adsorbers; followed by

a third switching action including switching at least one valve of the valve assembly to initiate said providing of said process fluid for binding a component of interest.

3. A method according to claim 2 wherein said at least one regenerating fluid has functionality to clean, sanitize and/or strip and/or equilibrate the membrane adsorbers prior to binding the component of interest.

4. A method according to claim 1 , wherein said plurality of valves is combined in at least one modular disposable format valve cassette.

5. A method according to claim 1 , wherein said membrane adsorber cartridge has adsorber functionality using affinity chromatography, ion exchange chromatography and/or mixed mode chromatography to bind and elute a product of interest.

6. The method according to claim 5 wherein the steps are performed to purify recombinant protein products.

7. A method according to claim 1 , wherein said membrane adsorber cartridge has adsorber functionality using protein A chromatography, cation exchange and/or mixed mode ligands.

8. The method according to claim 7 wherein the steps are performed to purify monoclonal antibodies.

9. A method according to claim 1 , wherein said membrane adsorber cartridge has adsorber functionality using affinity chromatography, ion exchange or mixed mode ligands.

10. The method according to claim 9 wherein the steps are performed to purify DNA or viral vectors.

11. A method according to claim 1 , wherein said process steps include, in an iterative way:

performing a binding action including providing a process fluid in at least one of said plurality of membrane adsorber cartridges for binding a group of contaminants to a membrane adsorber provided in said at least one membrane adsorber cartridge; and

performing a regenerating action including providing at least one regenerating fluid in said at least one adsorber cartridge to the membrane adsorbers prior to the binding action, wherein a first switching action including switching at least one valve of the valve assembly initiates said regenerating action; and wherein a second switching action including switching at least one valve of the valve assembly initiates said binding action.

12. A method according to claim 11 , wherein at least one regenerating fluid has desorbing functionality to desorb a contaminant from the at least one membrane adsorber.

13. A method according to claim 11 wherein said at least one regenerating fluid has functionality to clean, sanitize and/or strip and/or equilibrate the membrane adsorbers prior to binding the component of interest.

14. The method according to claim 11 wherein the steps are performed to polish monoclonal antibodies, recombinant proteins, viral vectors or DNA products.

15. The method of claim 1 wherein, after initiating the elution action by performing the first action, the second switching action is performed to repeat the binding action until a stopping criterion is reached, and wherein the stopping criterion is taken from the group consisting of: a time period elapses, and a concentration of a specific product is reached.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2025
From: PROPHARMA GROUP EUROPE B.V.
To: SARTORIUS STEDIM CHROMATOGRAPHY SYSTEMS LTD.
Reel/Frame 073027/0948 →
PARTIAL RELEASE OF FIRST LIEN SECURITY INTEREST IN PATENTS Recorded Feb 11, 2025
From: PNC BANK, NATIONAL ASSOCIATION
To: PROPHARMA GROUP EUROPE B.V.
Reel/Frame 070173/0936 →
RELEASE OF SECURITY INTEREST Recorded Feb 10, 2025
From: CRESCENT AGENCY SERVICES LLC, AS COLLATERAL AGENT
To: PROPHARMA GROUP EUROPE B.V.
Reel/Frame 070171/0086 →
SECURITY INTEREST Recorded Oct 20, 2020
From: PROPHARMA GROUP EUROPE B.V.
To: CRESCENT AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 054111/0606 →
SECURITY INTEREST Recorded Oct 15, 2020
From: PROPHARMA GROUP EUROPE B.V.
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 054062/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2019
From: GEZES HOLDING B.V.
To: PROPHARMA GROUP EUROPE B.V.
Reel/Frame 050381/0396 →
CHANGE OF NAME Recorded Sep 16, 2019
From: XENDO HOLDING B.V.
To: GEZES HOLDING B.V.
Reel/Frame 050382/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2010
From: BISSCHOPS, MARC ANTONIUS THEODORUS; PENNINGS, JOZEF ANTON MARI; TIJSTERMAN, JACOB ARTHUR
To: XENDO HOLDING B.V.
Reel/Frame 023889/0491 →
Continuity (1)
Related Publication 20100144028A1 · Jun 10, 2010